Results 221 to 230 of about 10,462,861 (343)
Neuroprotective effects of ursodeoxycholic acid in Parkinson's disease and Alzheimer's disease
In Parkinson's disease (PD) and Alzheimer's disease (AD), various shared pathological mechanisms exist. UDCA has been shown to exert neuroprotective effects in preclinical and clinical studies. Such effects include the mitigation of neuroinflammation as well as rescue effects on mitochondrial dysfunction, oxidative stress, impaired autophagy, and ...
Ashley En Yi Chong +3 more
wiley +1 more source
Clinical correlation analysis between vitamin A in Crohn disease combined with anemia. [PDF]
Qian K +7 more
europepmc +1 more source
Redefining “Comorbidity” in Dermatology: Beyond Terminology, Lessons From Other Specialties
JEADV Clinical Practice, EarlyView.
Patricia Garbayo‐Salmons +1 more
wiley +1 more source
ABSTRACT Colorectal cancer (CRC) is a leading cause of cancer mortality in the United States. Many patients with CRC experience physical and psychological symptoms that diminish quality of life and are shaped by social determinants of health (SDOH) and diet quality.
Youran Lee +18 more
wiley +1 more source
Vulvar Crohn disease: A case report. [PDF]
Kreutz J, Jensen C, Dytoc M.
europepmc +1 more source
ABSTRACT Limited evidence of nutritional deficiencies has been identified in bioarchaeological studies of Native California populations, although isotopic and ethnohistoric research provides evidence of regional, seasonal, and cultural variability in food shortages.
Alyson Caine +3 more
wiley +1 more source
Characterization of mesocolic adipose hyperplasia in a rat 2,4,6-trinitrobenzenesulfonic acid colitis model and comparison to creeping fat in Crohn disease. [PDF]
Clua L +13 more
europepmc +1 more source
Adenocarcinoma as a complication of small bowel Crohn\u27s disease
Carcinoma is a recognized but rare complication of small bowel Crohn\u27s disease. This case series emphasizes the importance of considering this diagnosis in patients with small bowel Crohn\u27s disease.
Thompson N +3 more
core
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone +3 more
wiley +1 more source

